Loading…
image

Report Scope & Overview:

Pathology Devices Market Was Valued At USD 311.2 Billion In 2021 And Is Expected To Expand At A Compound Annual Growth Rate (CAGR) Of 7.86% From 2022 To 2030.

Pathology Devices Market Overview:
Global Pathology Devices Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Pathology Devices Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
 
Overall, Pathology Devices market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Pathology Devices market research is expected to experience further growth and innovation in the coming years.

DESCIMG1

Pathology Devices Market Key Trends

Digital Pathology: Digital pathology is a rapidly growing trend that involves scanning glass slides and converting them into digital images for analysis and storage. This technology enables remote access to images, enhances collaboration among pathologists, and facilitates integration with artificial intelligence (AI) algorithms for automated analysis.

Automation and AI: Automation and AI technologies are increasingly being integrated into pathology devices to improve efficiency and accuracy in diagnosis. AI algorithms can assist pathologists in analyzing large volumes of data, identifying patterns, and making more accurate diagnoses. Automated systems for slide staining, tissue processing, and sample preparation are also gaining traction.

Molecular Pathology: Molecular pathology focuses on the study of genetic and molecular changes in tissues and cells, and it plays a crucial role in personalized medicine and targeted therapies. Pathology devices that enable molecular testing, such as next-generation sequencing (NGS) platforms, polymerase chain reaction (PCR) instruments, and in situ hybridization (ISH) systems, are in high demand.

Point-of-Care Testing: Point-of-care testing (POCT) refers to the ability to perform diagnostic tests near the patient, without the need for samples to be sent to a central laboratory. In pathology, POCT devices are becoming more advanced and accessible, allowing rapid diagnosis and treatment decisions in various healthcare settings, including clinics, emergency departments, and ambulances.

Telepathology: Telepathology involves the remote transmission of pathology images and data for consultation, education, and research purposes. It enables pathologists to collaborate and seek expert opinions regardless of geographical boundaries. The adoption of telepathology has increased with the expansion of digital pathology solutions and improvements in internet connectivity.

Integration with Laboratory Information Systems (LIS): Pathology devices are increasingly being integrated with laboratory information systems (LIS) to streamline workflow, improve data management, and enhance overall operational efficiency. Integration allows seamless transfer of patient data, results, and images between various devices and systems within the laboratory.

Personalized Medicine: The shift towards personalized medicine, which aims to tailor medical treatments to individual patients based on their unique characteristics, is influencing the pathology devices market. The demand for devices that enable molecular profiling, companion diagnostics, and targeted therapies is increasing as personalized medicine gains prominence.

Increasing Cancer Cases: The rising incidence of cancer globally is driving the demand for pathology devices. Pathology plays a crucial role in cancer diagnosis, staging, and treatment decisions. Therefore, there is a growing need for advanced devices that can handle the increasing workload and provide accurate and timely results.

Market Segmentations:

Global Pathology Devices Market: By Company
• Becton, Dickson and Company
• Ortho-Clinical Diagnostics
• Roche Diagnostics
• Abbott Laboratories
• Johnson and Johnson
• Danaher
• Roche(Ventana Medical Systems)
• Hamamatsu Photonics
• Mikroscan Technologies
• Definiens
• Visiopharm
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• Sysmex
• bioMérieux
• 3DHistech
• Quest Diagnostics

Global Pathology Devices Market: By Type
• Immunoassays Technology
• Clinical Chemistry
• Hematology
• Microbiology
• Molecular Diagnostics

Global Pathology Devices Market: By Application
• Disease Diagnostics
• Drug Discovery and Development
• Forensic Diagnostics

Global Pathology Devices Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Pathology Devices market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Report Attribute/MetricDetails
Market Size 2021USD 311.2 Billion
Compound Annual Growth Rate (CAGR)  7.86%(2022-2030)
Base Year2022
Forecast Period2022-2030
Historical Data2018-2020
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Immunoassays Technology
• Clinical Chemistry
• Hematology
• Microbiology
• Molecular Diagnostics
By Application• Disease Diagnostics
• Drug Discovery and Development
• Forensic Diagnostics
Key Companies Profiled• Becton, Dickson and Company
• Ortho-Clinical Diagnostics
• Roche Diagnostics
• Abbott Laboratories
• Johnson and Johnson
• Danaher
• Roche(Ventana Medical Systems)
• Hamamatsu Photonics
• Mikroscan Technologies
• Definiens
• Visiopharm
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• Sysmex
• bioMérieux
• 3DHistech
• Quest Diagnostics
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Pathology Devices Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.

Objectives of Pathology Devices Market Study:
The objectives of Pathology Devices market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Pathology Devices market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.

Frequently Asked Questions

  Pathology Devices Market Was Valued At USD 311.2 Billion In 2021 And Is Expected To Expand At A Compound Annual Growth Rate (CAGR) Of 7.86% From 2022 To 2030.

  The Pathology Devices market refers to the market for medical devices and instruments used in the diagnosis and study of diseases and conditions through laboratory analysis of tissue samples, body fluids, and cells. These devices assist pathologists and laboratory professionals in examining and analyzing specimens to determine the presence, nature, and progression of diseases.

  The growth of the Pathology Devices market is primarily driven by factors such as the increasing prevalence of chronic diseases, a growing aging population, technological advancements in diagnostic techniques, rising demand for personalized medicine, and the need for accurate and timely disease diagnosis.

  The Pathology Devices market is globally distributed, with significant market shares in regions such as North America, Europe, and Asia-Pacific. The United States, in particular, has a major market share due to its advanced healthcare infrastructure, high demand for diagnostic services, and technological advancements in pathology devices.

  The opportunities in the Pathology Devices market include the development of advanced imaging and analysis techniques, increasing adoption of digital pathology systems, the rise of companion diagnostics and personalized medicine, expansion into emerging markets with a growing demand for healthcare services, and the integration of artificial intelligence and machine learning in pathology diagnostics for enhanced accuracy and efficiency.The opportunities in the Pathology Devices market include the development of advanced imaging and analysis techniques, increasing adoption of digital pathology systems, the rise of companion diagnostics and personalized medicine, expansion into emerging markets with a growing demand for healthcare services, and the integration of artificial intelligence and machine learning in pathology diagnostics for enhanced accuracy and efficiency.

TABLE OF CONTENT

1 Pathology Devices Market Overview
1.1 Product Overview and Scope of Pathology Devices
1.2 Pathology Devices Segment by Type
1.2.1 Global Pathology Devices Market Value Comparison by Type (2023-2029)
1.2.2 Immunoassays Technology
1.2.3 Clinical Chemistry
1.2.4 Hematology
1.2.5 Microbiology
1.2.6 Molecular Diagnostics
1.3 Pathology Devices Segment by Application
1.3.1 Global Pathology Devices Market Value by Application: (2023-2029)
1.3.2 Disease Diagnostics
1.3.3 Drug Discovery and Development
1.3.4 Forensic Diagnostics
1.4 Global Pathology Devices Market Size Estimates and Forecasts
1.4.1 Global Pathology Devices Revenue 2017-2032
1.4.2 Global Pathology Devices Sales 2017-2032
1.4.3 Global Pathology Devices Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Pathology Devices Market Competition by Manufacturers
2.1 Global Pathology Devices Sales Market Share by Manufacturers (2017-2023)
2.2 Global Pathology Devices Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Pathology Devices Average Price by Manufacturers (2017-2023)
2.4 Global Pathology Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pathology Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pathology Devices, Product Type & Application
2.7 Pathology Devices Market Competitive Situation and Trends
2.7.1 Pathology Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pathology Devices Players Market Share by Revenue
2.7.3 Global Pathology Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pathology Devices Retrospective Market Scenario by Region
3.1 Global Pathology Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pathology Devices Global Pathology Devices Sales by Region: 2017-2032
3.2.1 Global Pathology Devices Sales by Region: 2017-2023
3.2.2 Global Pathology Devices Sales by Region: 2023-2032
3.3 Global Pathology Devices Global Pathology Devices Revenue by Region: 2017-2032
3.3.1 Global Pathology Devices Revenue by Region: 2017-2023
3.3.2 Global Pathology Devices Revenue by Region: 2023-2032
3.4 North America Pathology Devices Market Facts & Figures by Country
3.4.1 North America Pathology Devices Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Pathology Devices Sales by Country (2017-2032)
3.4.3 North America Pathology Devices Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pathology Devices Market Facts & Figures by Country
3.5.1 Europe Pathology Devices Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Pathology Devices Sales by Country (2017-2032)
3.5.3 Europe Pathology Devices Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pathology Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Pathology Devices Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Pathology Devices Sales by Country (2017-2032)
3.6.3 Asia Pacific Pathology Devices Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pathology Devices Market Facts & Figures by Country
3.7.1 Latin America Pathology Devices Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Pathology Devices Sales by Country (2017-2032)
3.7.3 Latin America Pathology Devices Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pathology Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Pathology Devices Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Pathology Devices Sales by Country (2017-2032)
3.8.3 Middle East and Africa Pathology Devices Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pathology Devices Sales by Type (2017-2032)
4.1.1 Global Pathology Devices Sales by Type (2017-2023)
4.1.2 Global Pathology Devices Sales by Type (2023-2032)
4.1.3 Global Pathology Devices Sales Market Share by Type (2017-2032)
4.2 Global Pathology Devices Revenue by Type (2017-2032)
4.2.1 Global Pathology Devices Revenue by Type (2017-2023)
4.2.2 Global Pathology Devices Revenue by Type (2023-2032)
4.2.3 Global Pathology Devices Revenue Market Share by Type (2017-2032)
4.3 Global Pathology Devices Price by Type (2017-2032)
5 Segment by Application
5.1 Global Pathology Devices Sales by Application (2017-2032)
5.1.1 Global Pathology Devices Sales by Application (2017-2023)
5.1.2 Global Pathology Devices Sales by Application (2023-2032)
5.1.3 Global Pathology Devices Sales Market Share by Application (2017-2032)
5.2 Global Pathology Devices Revenue by Application (2017-2032)
5.2.1 Global Pathology Devices Revenue by Application (2017-2023)
5.2.2 Global Pathology Devices Revenue by Application (2023-2032)
5.2.3 Global Pathology Devices Revenue Market Share by Application (2017-2032)
5.3 Global Pathology Devices Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Becton, Dickson and Company
6.1.1 Becton, Dickson and Company Corporation Information
6.1.2 Becton, Dickson and Company Description and Business Overview
6.1.3 Becton, Dickson and Company Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Becton, Dickson and Company Pathology Devices Product Portfolio
6.1.5 Becton, Dickson and Company Recent Developments/Updates
6.2 Ortho-Clinical Diagnostics
6.2.1 Ortho-Clinical Diagnostics Corporation Information
6.2.2 Ortho-Clinical Diagnostics Description and Business Overview
6.2.3 Ortho-Clinical Diagnostics Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Ortho-Clinical Diagnostics Pathology Devices Product Portfolio
6.2.5 Ortho-Clinical Diagnostics Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Roche Diagnostics Pathology Devices Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Abbott Laboratories Pathology Devices Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Johnson and Johnson
6.5.1 Johnson and Johnson Corporation Information
6.5.2 Johnson and Johnson Description and Business Overview
6.5.3 Johnson and Johnson Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Johnson and Johnson Pathology Devices Product Portfolio
6.5.5 Johnson and Johnson Recent Developments/Updates
6.6 Danaher
6.6.1 Danaher Corporation Information
6.6.2 Danaher Description and Business Overview
6.6.3 Danaher Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Danaher Pathology Devices Product Portfolio
6.6.5 Danaher Recent Developments/Updates
6.7 Roche(Ventana Medical Systems)
6.6.1 Roche(Ventana Medical Systems) Corporation Information
6.6.2 Roche(Ventana Medical Systems) Description and Business Overview
6.6.3 Roche(Ventana Medical Systems) Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Roche(Ventana Medical Systems) Pathology Devices Product Portfolio
6.7.5 Roche(Ventana Medical Systems) Recent Developments/Updates
6.8 Hamamatsu Photonics
6.8.1 Hamamatsu Photonics Corporation Information
6.8.2 Hamamatsu Photonics Description and Business Overview
6.8.3 Hamamatsu Photonics Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Hamamatsu Photonics Pathology Devices Product Portfolio
6.8.5 Hamamatsu Photonics Recent Developments/Updates
6.9 Mikroscan Technologies
6.9.1 Mikroscan Technologies Corporation Information
6.9.2 Mikroscan Technologies Description and Business Overview
6.9.3 Mikroscan Technologies Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Mikroscan Technologies Pathology Devices Product Portfolio
6.9.5 Mikroscan Technologies Recent Developments/Updates
6.10 Definiens
6.10.1 Definiens Corporation Information
6.10.2 Definiens Description and Business Overview
6.10.3 Definiens Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Definiens Pathology Devices Product Portfolio
6.10.5 Definiens Recent Developments/Updates
6.11 Visiopharm
6.11.1 Visiopharm Corporation Information
6.11.2 Visiopharm Pathology Devices Description and Business Overview
6.11.3 Visiopharm Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Visiopharm Pathology Devices Product Portfolio
6.11.5 Visiopharm Recent Developments/Updates
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Corporation Information
6.12.2 Thermo Fisher Scientific Pathology Devices Description and Business Overview
6.12.3 Thermo Fisher Scientific Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Thermo Fisher Scientific Pathology Devices Product Portfolio
6.12.5 Thermo Fisher Scientific Recent Developments/Updates
6.13 Siemens Healthcare
6.13.1 Siemens Healthcare Corporation Information
6.13.2 Siemens Healthcare Pathology Devices Description and Business Overview
6.13.3 Siemens Healthcare Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Siemens Healthcare Pathology Devices Product Portfolio
6.13.5 Siemens Healthcare Recent Developments/Updates
6.14 Bio-Rad Laboratories
6.14.1 Bio-Rad Laboratories Corporation Information
6.14.2 Bio-Rad Laboratories Pathology Devices Description and Business Overview
6.14.3 Bio-Rad Laboratories Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Bio-Rad Laboratories Pathology Devices Product Portfolio
6.14.5 Bio-Rad Laboratories Recent Developments/Updates
6.15 Sysmex
6.15.1 Sysmex Corporation Information
6.15.2 Sysmex Pathology Devices Description and Business Overview
6.15.3 Sysmex Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Sysmex Pathology Devices Product Portfolio
6.15.5 Sysmex Recent Developments/Updates
6.16 bioMérieux
6.16.1 bioMérieux Corporation Information
6.16.2 bioMérieux Pathology Devices Description and Business Overview
6.16.3 bioMérieux Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.16.4 bioMérieux Pathology Devices Product Portfolio
6.16.5 bioMérieux Recent Developments/Updates
6.17 3DHistech
6.17.1 3DHistech Corporation Information
6.17.2 3DHistech Pathology Devices Description and Business Overview
6.17.3 3DHistech Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.17.4 3DHistech Pathology Devices Product Portfolio
6.17.5 3DHistech Recent Developments/Updates
6.18 Quest Diagnostics
6.18.1 Quest Diagnostics Corporation Information
6.18.2 Quest Diagnostics Pathology Devices Description and Business Overview
6.18.3 Quest Diagnostics Pathology Devices Sales, Revenue and Gross Margin (2017-2023)
6.18.4 Quest Diagnostics Pathology Devices Product Portfolio
6.18.5 Quest Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pathology Devices Industry Chain Analysis
7.2 Pathology Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pathology Devices Production Mode & Process
7.4 Pathology Devices Sales and Marketing
7.4.1 Pathology Devices Sales Channels
7.4.2 Pathology Devices Distributors
7.5 Pathology Devices Customers
8 Pathology Devices Market Dynamics
8.1 Pathology Devices Industry Trends
8.2 Pathology Devices Market Drivers
8.3 Pathology Devices Market Challenges
8.4 Pathology Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Becton, Dickson and Company
Ortho-Clinical Diagnostics
Roche Diagnostics
Abbott Laboratories
Johnson and Johnson
Danaher
Roche(Ventana Medical Systems)
Hamamatsu Photonics
Mikroscan Technologies
Definiens
Visiopharm
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
Sysmex
bioMérieux
3DHistech
Quest Diagnostics

Request Sample